Finerenone (Bayer) Market Overview and Drug Profile 2017-2026
Dublin, June 25, 2019 (GLOBE NEWSWIRE) -- The "Finerenone" report has been added to ResearchAndMarkets.com's offering. Finerenone (Bayer) is a third-generation potent and selective oral, non-steroidal mineralocorticoid receptor antagonist ( …